MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK PathwaysMeng Ma, Jun Guo, Chuanliang Cui et al.|Theranostics|2019Cited by 70
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyXue Bai, Keith T. Flaherty, Shaheen Ahmed et al.|EClinicalMedicine|2023Cited by 26
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trialHui‐Chuan Sun, Xiao‐Dong Zhu, Jun Fan et al.|Annals of Oncology|2025Cited by 3